CVS Health (CVS)
(Real Time Quote from BATS)
$56.94 USD
-0.68 (-1.18%)
Updated Jul 10, 2024 01:32 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CVS 56.94 -0.68(-1.18%)
Will CVS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CVS
CVS Health (CVS) Falls 24% in 3 Months: Should You Buy the Dip?
CVS Health (CVS) Gains As Market Dips: What You Should Know
CVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
UnitedHealth (UNH) Stock Drops 8% YTD: Should You Hold or Fold?
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Other News for CVS
CVS Health announces quarterly dividend
CVS Health to hold second quarter 2024 earnings conference call
Walgreens Boots Alliance: Maybe I Was Wrong
UnitedHealth, Humana seen as managed care beneficiaries in second Trump term
RBC says presidential debate bodes well for managed care stocks